Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00103896
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2005-02-15
Brief Title:
Connect to Protect Partnerships for Youth Prevention Interventions Phase II
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Study Overview
Official Title:
Connect to Protect C2P Partnerships for Youth Prevention Interventions Phase II
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is Phase II of a three stage project whose overall goals are to develop viable community-based HIV prevention interventions and to form and maintain the necessary community collaborations to support such Adolescent Trials Network ATN research activities
This phase will describe specific locations within high-risk areas where youth ages 12-24 spend time HIV risk behaviors social networking patterns and HIV prevalence among youth at these venues will be assessed by administering anonymous computerized interviews to eligible and willing youth This information will be shared with community partners during scheduled working group meetings
This phase will describe specific locations within high-risk areas where youth ages 12-24 spend time HIV risk behaviors social networking patterns and HIV prevalence among youth at these venues will be assessed by administering anonymous computerized interviews to eligible and willing youth This information will be shared with community partners during scheduled working group meetings
Detailed Description:
This is Phase II of a three stage project whose overall goals are to develop viable community-based HIV prevention interventions and to form and maintain the necessary community collaborations to support such ATN research activities
During this phase each ATN site will gather additional information within high-risk areas and solicit community partner input to ultimately pinpoint the specific locations where at-risk youths ages 12-24 may be recruited for interventions This will be done by the following methods
Venues will be identified by HIV youth at the ATN site by participation in an anonymous computerized interview Site staff will then perform brief venue interviews BVIs at selected venues to assess the potential yield of youths 12-24 years old Community partners will also provide the site staff with information on known high-risk venues High-risk venues will further be identified by the results of anonymous computerized interviews and HIV assays obtained from eligible and willing youth participants at the venues The interviews will gather information on HIV risk behaviors social networking patterns and HIV prevalence among youths at these venues This information will be shared with community partners during scheduled working group meetings
During this phase each ATN site will gather additional information within high-risk areas and solicit community partner input to ultimately pinpoint the specific locations where at-risk youths ages 12-24 may be recruited for interventions This will be done by the following methods
Venues will be identified by HIV youth at the ATN site by participation in an anonymous computerized interview Site staff will then perform brief venue interviews BVIs at selected venues to assess the potential yield of youths 12-24 years old Community partners will also provide the site staff with information on known high-risk venues High-risk venues will further be identified by the results of anonymous computerized interviews and HIV assays obtained from eligible and willing youth participants at the venues The interviews will gather information on HIV risk behaviors social networking patterns and HIV prevalence among youths at these venues This information will be shared with community partners during scheduled working group meetings
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None